Clinical Trial Update: Reducing Pain and Opioid Use With CBD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated cannabidiol (CBD) for reducing pain and opioid use in people with opioid use disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Opioid Use Disorder | Phase 2 | Status: COMPLETED